Cannabis for psychiatric disorders - Has The Pendulum Swung Too Far?

Shafiqa Alawadi; Ahmed Naguy

doi:10.1016/j.ajp.2021.102995

Cannabis for psychiatric disorders - Has The Pendulum Swung Too Far?

Asian J Psychiatr. 2022 Mar:69:102995. doi: 10.1016/j.ajp.2021.102995. Epub 2021 Dec 28.

Authors

Shafiqa Alawadi¹, Ahmed Naguy²

Affiliations

¹ Public Authority of the Disabled Affairs (PADA), And Faculty of Medicine, Kuwait University, State of Kuwait.
² Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Jamal Abdul-Nassir St, Shuwaikh, Kuwait. Electronic address: ahmednagy@hotmail.co.uk.

PMID: 34974321
DOI: 10.1016/j.ajp.2021.102995

Abstract

Strong interest in cannabinoids as potential treatment for psychiatric disorders has led to numerous studies. Particularly, cannabidiol (CBD) has promise as a pharmacotherapy for psychotic disorders as well as anxiety disorders. Herein we shed some light on therapeutic potential while examining extant evidence. Literature is still nascent. This should be balanced against the ubiquitous use of cannabis in patients with psychiatric disorders that has been strongly tied to frequent relapses and heightened violence.

Keywords: Anxiety disorders; Cannabidiol; Endocannabinoid system; Schizophrenia; Tetrahydrocannabinol.

Publication types

Letter

MeSH terms

Cannabidiol* / therapeutic use
Cannabinoids* / therapeutic use
Cannabis*
Hallucinogens*
Humans
Mental Disorders* / drug therapy

Substances

Cannabinoids
Hallucinogens
Cannabidiol